A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Longitudinal patterns and associated factors of postdiagnosis weight changes in Korean breast cancer survivors with normal body mass index.
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial